DK127417B - Process for the preparation of 9α- and / or 9β-hydroxy-11β-nitrooxysteroids with aromatic A-ring. - Google Patents

Process for the preparation of 9α- and / or 9β-hydroxy-11β-nitrooxysteroids with aromatic A-ring.

Info

Publication number
DK127417B
DK127417B DK589870A DK589870A DK127417B DK 127417 B DK127417 B DK 127417B DK 589870 A DK589870 A DK 589870A DK 589870 A DK589870 A DK 589870A DK 127417 B DK127417 B DK 127417B
Authority
DK
Denmark
Prior art keywords
nitrooxysteroids
hydroxy
aromatic
preparation
ring
Prior art date
Application number
DK589870A
Other languages
Danish (da)
Inventor
P Sykes
G Phillipps
S Laing
J Turnbull
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of DK127417B publication Critical patent/DK127417B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
DK589870A 1969-11-21 1970-11-20 Process for the preparation of 9α- and / or 9β-hydroxy-11β-nitrooxysteroids with aromatic A-ring. DK127417B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5708469 1969-11-21
GB5102870 1970-10-27

Publications (1)

Publication Number Publication Date
DK127417B true DK127417B (en) 1973-11-05

Family

ID=26266781

Family Applications (1)

Application Number Title Priority Date Filing Date
DK589870A DK127417B (en) 1969-11-21 1970-11-20 Process for the preparation of 9α- and / or 9β-hydroxy-11β-nitrooxysteroids with aromatic A-ring.

Country Status (4)

Country Link
DE (1) DE2057171A1 (en)
DK (1) DK127417B (en)
FR (1) FR2069758A5 (en)
NL (1) NL7017001A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9118465D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors

Also Published As

Publication number Publication date
FR2069758A5 (en) 1971-09-03
NL7017001A (en) 1971-05-25
DE2057171A1 (en) 1971-05-27

Similar Documents

Publication Publication Date Title
DK112949B (en) Process for the preparation of O-mycaminosyl tylonolide or dihydro-O-mycaminosyl tylonolide.
DK130306B (en) Analogous process for the preparation of S-trialkylphosphine gold-1-thio-β-D-glucopyranosides.
DK136314B (en) Analogous process for the preparation of benzamidoethylpiperazines.
DK134176B (en) Process for the preparation of furan-3-carboxamide derivatives.
DK133375B (en) Analogous process for the preparation of 1-carbamoyl-3-phenylpyrrolidines.
DK124946B (en) Analogous process for the preparation of evomonoside derivatives.
DK134489B (en) Process for the preparation of alkyl-7-deoxy-7 (S) -substituted-alpha-thiolincosaminides.
DK128006B (en) Analogous process for the preparation of 11-desacetoxy-wortmannin.
DK131863B (en) Analogous process for the preparation of thiazolino or thiazidino-pyrimidine derivatives.
DK133682B (en) Analogous process for the preparation of 3alpha-hydroxy-5alpha-pregn-1-en-20-ones or 3alpha-hydroxy-17beta-alkoxycarbonyl-5alpha-androst-1-ones.
DK122882B (en) Process for the preparation of kawain or methysticin.
DK128737B (en) Analogous process for the preparation of 6α-methyl-17α-caproyloxy-19-norprogesterone.
DK127417B (en) Process for the preparation of 9α- and / or 9β-hydroxy-11β-nitrooxysteroids with aromatic A-ring.
DK126323B (en) Process for the preparation of 3β-hydroxy-5α-cardenolides or buffadienolides.
DK123096B (en) Analogous process for the preparation of neriifoline derivatives.
DK122456B (en) Process for the preparation of quinoxaline-di-N-oxide-aldehyde.
DK122127B (en) Analogous process for the preparation of 3-phenyl-4-acyloxycarbostyriles.
DK123816B (en) Analogous process for the preparation of N-phenacylcarbamates.
DK130792B (en) Process for the preparation of cis-zearalenone or cis-zearalenol.
DK126784B (en) Process for the preparation of hydroquinoline compounds or hydroisoquinoline compounds.
DK129990B (en) Analogous process for the preparation of 3-oxo-13β-alkyl-17α-methyl-20β-hydroxy-18,19-di-nor-pregna-4,9-dienes or esters thereof.
DK129836B (en) Analogous process for the preparation of 21-fluoro-3β-hydroxy-pregna-5,16-dien-20-one or esters thereof.
DK126036B (en) Analogous process for the preparation of 3-oxo-13β-ethyl-7α, 17α-dimethyl-17β-hydroxy-4,9,11-gonatriene or esters thereof.
DK121165B (en) Process for the preparation of 1-aminoalkyl-1-arylindenar or 3-aminoalkyl-3-arylindan-1-ols.
DK131820B (en) Analogous process for the preparation of 4-aminoquinazolines or 1-aminoisoquinolines.